Unexpected cases of icterus gravidarum in infancy have in many instances been traced to drug absorption from the maternal circulation. After consulting with paediatricians, it was considered advisable to investigate under hospital supervision the effect, if any, of metronidazole ("Flagyl") on the foetus and later on the breast-fed infant.
In Edinburgh a "mother and baby" survey on 96 patients completed in December, 1960 (Scott Gray, 1961 , suggested that there was no placental barrier to the drug. The serum concentrations in mother and child were approximately equal at the time of delivery. The drug was well absorbed during labour, and in four cases where gastric lavage had been previously carried out the serum concentrations were higher than in the remaining cases investigated.
Serum bilirubin estimations performed on mothers and babies showed no appreciable increase. This paper presents the results of investigations into the secretion of metronidazole in breast milk and the absorption by the breast-fed infant.
Methods
The patients chosen for this project had uncomplicated ante-natal and post-natal histories. The average age of * Paper read at the M.S.S.V.D. meeting in Paris on May 12, 1961. the mother was 22-5 years and 5-day old babies were chosen, as at that age breast feeding should be well established. A delay until the seventh or tenth day was not advisable as after the initial engorgement of the breast, feeding difficulties may develop for both mother and child. All the babies were fed 4-hourly.
The ten patients were divided into two groups. Blood samples and breast milk were taken from the mother at 0, 4, and 8 hours in five patients (Group I) and also at 12 hours in the other five patients (Group II), after oral administration of one tablet of 200 mg. metronidazole. In Group I a blood sample was taken from the child at 8 hours (i.e. 4 hours after the first feed) and in Group II at 12 hours (i.e. 4 hours after the second feed). At each feed the child was test weighed. Serum and breast samples were analysed by the polarographic method (Kane, 1961) .
Results
The results of the investigation (Tables I and II) showed that the serum concentrations in the mother were similar to those found in a previous series of twelve non-maternity patients (Kane, McFadzean, Squires, King, and Nicol, 1961) . Concentrations of metronidazole in breast milk were comparable with those in the serum. The mean figures in Vg./ml. of breast milk concentrations at 4, 8, and 12 hours in the series were 3 4, 2 2, and 1 -3, compared with -3 9, 2 3, and 1 8 serum levels. The sera of five babies contained no detectable metronidazole (<0 05 sLg./ml.) and in the other five babies the amount ranged from -0 05 to 0 4 4 tg./ml.
We attempted to calculate the amount of drug ingested by the infant from the test weighings and the concentration of drug in milk. The average amount at the first feed was 0 3 mg. and at the second feed 0 17 mg. The maximum amount ingested by any one infant was 0 41 mg. There was no correlation between the amount of drug ingested by the infant and the concentrations found in the infant's serum.
Further studies will be carried out on lactating mothers receiving the standard 7-day course of metronidazole in order to ascertain whether a trichomonicidal serum concentration of the drug can be attained in the infants' serum and also to determine the total intake of drug by the infant. Such a survey will be delayed until further information is available on peak serum concentrations of metronidazole in non-maternity patients receiving a full course of therapy.
During the trials no baby developed any oral or gastro-intestinal upset.
The concentration of metronidazole has now been measured in seminal fluid, 8 hours after completion of a standard course of treatment. This was the first time such an estimation has been undertaken, and the figure of 4 8 ptg./ml., though provisional, may be of some significance in the treatment of male trichomoniasis.
Summary
The excretion of orally-administered metronidazole in breast milk and the blood levels obtained in both the mother and the suckling infant have been determined in a series of ten patients. Concentrations of the drug found in the breast milk were comparable with those found in the serum and were also similar to the serum concentrations found previously in a series of non-maternity cases.
The sera of five of the babies contained no detectable drug whilst in five others concentrations ranging from -0 05 to 0 4 .tg./ml. were found. Administration of the drug to the mother had no obvious effect on any of the babies and none of the children developed oral or gastro-intestinal upset.
